• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Sunday, October 4, 2026
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News

Science fiction book campaign results in a $22,000 charitable contribution

Bioengineer by Bioengineer
November 14, 2016
in Science News
Reading Time: 2 mins read
0
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

Springer Nature and Humble Bundle have raised a charitable contribution of $22,000 through the science fiction book campaign "Science Fiction by Real Scientists." One half of the proceeds, $11,000, goes to the Science Fiction & Fantasy Writers of America's Givers Fund. The same amount goes to the U.S. Fund for UNICEF as part of the global children's charity's annual Halloween fundraising drive. Humble Bundle supports a number of charities by offering media packages to its customers on a pay-what-you-want basis.

During the campaign, Springer offered a specially priced eBook bundle from its Science and Fiction series, consisting of nine full novels, two books of short stories and five nonfiction books. Readers were able to choose how their purchase dollars were allocated between the publisher and charity. Starting at just one dollar, customers could name their price, increasing their contribution to upgrade their bundles or contribute more to charity.

The Science and Fiction series, launched in 2012 by Springer, is a unique publishing program for fiction written by actual scientists and experts in scientific fields. Each novel or anthology of short stories is accompanied by an extensive afterword that explains, in lay terms, the current scientific theory or findings that serve as the basis for the fictional work.

Mia Kravitz, Director Global eRetail at Springer Nature, said, "Springer was so pleased to work with Humble Bundle on this worthwhile effort to aid children globally as well as support writers and artists in the science fiction genre. Pushing the envelope for scientific inquiry is part of our mission, and this is a fun way to bring current research to a wider audience."

###

Springer is part of Springer Nature, a leading global research, educational and professional publisher, home to an array of respected and trusted brands providing quality content through a range of innovative products and services. Springer Nature is the world's largest academic book publisher, publisher of the world's most influential journals and a pioneer in the field of open research. The company numbers almost 13,000 staff in over 50 countries. Springer Nature was formed in 2015 through the merger of Nature Publishing Group, Palgrave Macmillan, Macmillan Education and Springer Science+Business Media. Visit http://www.springernature.com and follow @SpringerNature.

Media Contact

Joan Robinson
[email protected]
49-622-148-78130
@SpringerNature

http://www.springer.com

############

Story Source: Materials provided by Scienmag

Share12Tweet8Share2ShareShareShare2

Related Posts

New Study Examines How Dedicated Dermatology Textbooks Represent Skin of Colour

New Study Examines How Dedicated Dermatology Textbooks Represent Skin of Colour

October 4, 2026
Adding Immunotherapy to Chemo and Bevacizumab Extends Survival in Recurrent Cervical Cancer

Adding Immunotherapy to Chemo and Bevacizumab Extends Survival in Recurrent Cervical Cancer

October 4, 2026

Forskolin Extract Boosts Gut Hormone GLP-1 and Strengthens Intestinal Barrier in Cell Study

October 4, 2026

Empathy, Not Mood, Drives Helping in Autistic Children, Study Finds

October 4, 2026
Please login to join discussion

POPULAR NEWS

  • Alloys That Shrink Their Own Grains: New PIX Mechanism Refines Metals With Heat Alone

    Alloys That Shrink Their Own Grains: New PIX Mechanism Refines Metals With Heat Alone

    29 shares
    Share 12 Tweet 7
  • Endurance Exercise Reshapes the Liver in Males and Females Through Distinct Molecular Routes

    29 shares
    Share 12 Tweet 7
  • Single Transcription Factor PU.1 Rapidly Converts Fibroblasts into Macrophage-Lineage Cells

    29 shares
    Share 12 Tweet 7
  • New Scale Measures How Ready Nurse Educators Really Are for the AI Era

    29 shares
    Share 12 Tweet 7

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Alloys That Shrink Their Own Grains: New PIX Mechanism Refines Metals With Heat Alone

Endurance Exercise Reshapes the Liver in Males and Females Through Distinct Molecular Routes

Single Transcription Factor PU.1 Rapidly Converts Fibroblasts into Macrophage-Lineage Cells

Subscribe to Blog via Email

Success! An email was just sent to confirm your subscription. Please find the email now and click 'Confirm' to start subscribing.

Join 85 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.